| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4407163
[patent_doc_number] => 06309848
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-30
[patent_title] => 'Human xenografts for microbicide testing and anatomical modeling'
[patent_app_type] => 1
[patent_app_number] => 9/624318
[patent_app_country] => US
[patent_app_date] => 2000-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9706
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/309/06309848.pdf
[firstpage_image] =>[orig_patent_app_number] => 624318
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/624318 | Human xenografts for microbicide testing and anatomical modeling | Jul 23, 2000 | Issued |
Array
(
[id] => 4316075
[patent_doc_number] => 06316689
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => '25-hydroxyvitamin D3 24-hydroylase transgenic rats'
[patent_app_type] => 1
[patent_app_number] => 9/423011
[patent_app_country] => US
[patent_app_date] => 1999-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18916
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/316/06316689.pdf
[firstpage_image] =>[orig_patent_app_number] => 423011
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/423011 | 25-hydroxyvitamin D3 24-hydroylase transgenic rats | Oct 26, 1999 | Issued |
| 09/400497 | HEPATITIS B CORE ANTIGEN NUCLEIC ACID VACCINE | Sep 20, 1999 | Abandoned |
| 09/395368 | EMBRYONIC OR STEM-LIKE CELL LINES PRODUCED BY CROSS SPECIES NUCLEAR TRANSPLANTATION AND METHODS FOR ENHANCING EMBRYONIC DEVELOPMENT BY GENETIC ALTERATION OF DONOR CELLS OR BY TISSUE CULTURE CONDITIONS | Sep 13, 1999 | Abandoned |
| 09/356987 | METHODS OF PREFORMING HOMOLOGOUS RECOMBINATION BASED MODIFICATION OF NUCLEIC ACIDS IN RECOMBINATION DEFICIENT CELLS AND USE OF THE MODIFIED NUCLEIC ACID PRODUCTS THEREOF | Jul 19, 1999 | Abandoned |
Array
(
[id] => 4302849
[patent_doc_number] => 06326205
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Methods for use of Mpl ligands with primitive human stem cells'
[patent_app_type] => 1
[patent_app_number] => 9/328188
[patent_app_country] => US
[patent_app_date] => 1999-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 19
[patent_no_of_words] => 15176
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326205.pdf
[firstpage_image] =>[orig_patent_app_number] => 328188
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/328188 | Methods for use of Mpl ligands with primitive human stem cells | Jun 7, 1999 | Issued |
Array
(
[id] => 4241899
[patent_doc_number] => 06166287
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-26
[patent_title] => 'Corticotropin-releasing factor overproducing transgenic mice'
[patent_app_type] => 1
[patent_app_number] => 9/325926
[patent_app_country] => US
[patent_app_date] => 1999-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 8438
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/166/06166287.pdf
[firstpage_image] =>[orig_patent_app_number] => 325926
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/325926 | Corticotropin-releasing factor overproducing transgenic mice | Jun 3, 1999 | Issued |
Array
(
[id] => 4275067
[patent_doc_number] => 06245966
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-12
[patent_title] => 'Adenoviral mediated gene transfer into lymphocytes'
[patent_app_type] => 1
[patent_app_number] => 9/272496
[patent_app_country] => US
[patent_app_date] => 1999-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 8049
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/245/06245966.pdf
[firstpage_image] =>[orig_patent_app_number] => 272496
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/272496 | Adenoviral mediated gene transfer into lymphocytes | Mar 18, 1999 | Issued |
Array
(
[id] => 4320138
[patent_doc_number] => 06248725
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-19
[patent_title] => 'Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction'
[patent_app_type] => 1
[patent_app_number] => 9/256630
[patent_app_country] => US
[patent_app_date] => 1999-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 8667
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/248/06248725.pdf
[firstpage_image] =>[orig_patent_app_number] => 256630
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/256630 | Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction | Feb 22, 1999 | Issued |
Array
(
[id] => 4409622
[patent_doc_number] => 06265390
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-24
[patent_title] => 'Methods for expressing nucleic acid sequences using nucleic acid constructs comprising hypoxia response elements'
[patent_app_type] => 1
[patent_app_number] => 9/253738
[patent_app_country] => US
[patent_app_date] => 1999-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 6557
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/265/06265390.pdf
[firstpage_image] =>[orig_patent_app_number] => 253738
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/253738 | Methods for expressing nucleic acid sequences using nucleic acid constructs comprising hypoxia response elements | Feb 21, 1999 | Issued |
Array
(
[id] => 4310404
[patent_doc_number] => 06242182
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => 'Methods for haplotyping Rfp-Y and B-F genes in chicken'
[patent_app_type] => 1
[patent_app_number] => 9/244093
[patent_app_country] => US
[patent_app_date] => 1999-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5567
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/242/06242182.pdf
[firstpage_image] =>[orig_patent_app_number] => 244093
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/244093 | Methods for haplotyping Rfp-Y and B-F genes in chicken | Feb 3, 1999 | Issued |
Array
(
[id] => 4316117
[patent_doc_number] => 06316692
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies'
[patent_app_type] => 1
[patent_app_number] => 9/191920
[patent_app_country] => US
[patent_app_date] => 1998-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9598
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/316/06316692.pdf
[firstpage_image] =>[orig_patent_app_number] => 191920
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/191920 | Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies | Nov 12, 1998 | Issued |
Array
(
[id] => 4323360
[patent_doc_number] => 06248934
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-19
[patent_title] => 'Gene trap vectors'
[patent_app_type] => 1
[patent_app_number] => 9/191652
[patent_app_country] => US
[patent_app_date] => 1998-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5243
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/248/06248934.pdf
[firstpage_image] =>[orig_patent_app_number] => 191652
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/191652 | Gene trap vectors | Nov 12, 1998 | Issued |
Array
(
[id] => 4181457
[patent_doc_number] => 06150170
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same'
[patent_app_type] => 1
[patent_app_number] => 9/126220
[patent_app_country] => US
[patent_app_date] => 1998-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14404
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/150/06150170.pdf
[firstpage_image] =>[orig_patent_app_number] => 126220
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/126220 | Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same | Jul 29, 1998 | Issued |
| 09/116298 | GENE TARGETING IN ANIMAL CELLS USING ISOGENIC DNA CONSTRUCTS | Jul 14, 1998 | Abandoned |
Array
(
[id] => 4271615
[patent_doc_number] => 06245747
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-12
[patent_title] => 'Targeted site specific antisense oligodeoxynucleotide delivery method'
[patent_app_type] => 1
[patent_app_number] => 9/114399
[patent_app_country] => US
[patent_app_date] => 1998-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12674
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/245/06245747.pdf
[firstpage_image] =>[orig_patent_app_number] => 114399
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/114399 | Targeted site specific antisense oligodeoxynucleotide delivery method | Jul 12, 1998 | Issued |
| 09/096732 | CHIMERIC TRANSCRIPTION FACTORS | Jun 10, 1998 | Abandoned |
| 09/088766 | USE OF A 1B1 INTEGRIN RECEPTOR BLOCKING AGENTS IN KIDNEY DIEASE | Jun 1, 1998 | Abandoned |
Array
(
[id] => 4275839
[patent_doc_number] => 06323390
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Transgenic mouse models for human bladder cancer'
[patent_app_type] => 1
[patent_app_number] => 9/083541
[patent_app_country] => US
[patent_app_date] => 1998-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 27
[patent_no_of_words] => 13488
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/323/06323390.pdf
[firstpage_image] =>[orig_patent_app_number] => 083541
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/083541 | Transgenic mouse models for human bladder cancer | May 21, 1998 | Issued |
| 09/071386 | HOST DEFENSE ENHANCEMENT | Apr 29, 1998 | Abandoned |